Cargando…

Mucopolysaccharidosis type I: molecular characteristics of two novel alpha-L-iduronidase mutations in Tunisian patients

ABSTRACT: BACKGROUND: Mucopolysaccharidosis type I (MPS I) is an autosomal storage disease resulting from defective activity of the enzyme α-L-iduronidase (IDUA). This glycosidase is involved in the degradation of heparan sulfate and dermatan sulfate. MPS I has severe and milder phenotypic subtypes....

Descripción completa

Detalles Bibliográficos
Autores principales:	Chkioua, Latifa, Khedhiri, Souhir, Turkia, Hadhami Ben, Tcheng, Rémy, Froissart, Roseline, Chahed, Henda, Ferchichi, Salima, Ben Dridi, Marie Françoise, Vianey-Saban, Christine, Laradi, Sandrine, Miled, Abdelhedi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3135498/ https://www.ncbi.nlm.nih.gov/pubmed/21639919 http://dx.doi.org/10.1186/1746-1596-6-47

Ejemplares similares

Molecular analysis of iduronate -2- sulfatase gene in Tunisian patients with mucopolysaccharidosis type II
por: Chkioua, Latifa, et al.
Publicado: (2011)

Hurler disease (mucopolysaccharidosis type IH): clinical features and consanguinity in Tunisian population
por: Chkioua, Latifa, et al.
Publicado: (2011)

Molecular analysis of mucopolysaccharidosis type I in Tunisia: identification of novel mutation and eight Novel polymorphisms
por: Chkioua, Latifa, et al.
Publicado: (2011)

Genetic basis of cystinosis in Tunisian patients: Identification of novel mutation in CTNS gene
por: Chkioua, Latifa, et al.
Publicado: (2015)

Molecular analysis in a GALNS study cohort of 15 Tunisian patients: description of a novel mutation
por: Chkioua, Latifa, et al.
Publicado: (2016)

Polymorphisms in Tunisian patients with N-acetylgalactosamine-6-sulfate sulfatase gene deficiency: Implication in Morquio A disease
por: Khedhiri, Souhir, et al.
Publicado: (2011)

Hsp70-2 gene polymorphism: susceptibility implication in Tunisian patients with coronary artery disease
por: Hrira, Mohamed Yahia, et al.
Publicado: (2012)

Novel splice site IDUA gene mutation in Tunisian pedigrees with hurler syndrome
por: Chkioua, Latifa, et al.
Publicado: (2018)

Molecular characterization of CTNS mutations in Tunisian patients with ocular cystinosis
por: Chkioua, Latifa, et al.
Publicado: (2022)

Hepatic Proteins and Inflammatory Markers in Rheumatoid Arthritis Patients
por: BEN-HADJ-MOHAMED, Manel, et al.
Publicado: (2017)

Low erythrocyte catalase enzyme activity is correlated with high serum total homocysteine levels in tunisian patients with acute myocardial infarction
por: Noichri, Yosri, et al.
Publicado: (2013)

Fucosidosis in Tunisian patients: mutational analysis and homology-based modeling of FUCA1 enzyme
por: Chkioua, Latifa, et al.
Publicado: (2021)

Correction to: Fucosidosis in Tunisian patients: mutational analysis and homology-based modeling of FUCA1 enzyme
por: Chkioua, Latifa, et al.
Publicado: (2021)

Correlation of Oxidative Stress Parameters and Inflammatory Markers in Tunisian Coronary Artery Disease Patients
por: Dandana, Azza, et al.
Publicado: (2011)

The mutational spectrum of hunter syndrome reveals correlation between biochemical and clinical profiles in Tunisian patients
por: Chkioua, L, et al.
Publicado: (2020)

Brain MRI and biological diagnosis in five Tunisians MLD patients
por: Barboura, Ilhem, et al.
Publicado: (2012)

Evaluation of physiological risk factors, oxidant-antioxidant imbalance, proteolytic and genetic variations of matrix metalloproteinase-9 in patients with pressure ulcer
por: Latifa, Khlifi, et al.
Publicado: (2016)

α-L-iduronidase therapy for mucopolysaccharidosis type I
por: Tolar, Jakub, et al.
Publicado: (2008)

Clinical Utility of Serum Cystatin C in Predicting Coronary Artery Disease in Patients Without Chronic Kidney Disease
por: Dandana, Azza, et al.
Publicado: (2014)

Insights into Mucopolysaccharidosis I from the structure and action of α-L-Iduronidase
por: Bie, Haiying, et al.
Publicado: (2013)

Pathological interactions between the endothelin-1 and the angiotensin- converting enzyme among Tunisian coronary patients
por: Chalghoum, Abdelkader, et al.
Publicado: (2016)

Biochemical Responses to Level-1 Yo-Yo Intermittent Recovery Test in Young Tunisian Football Players
por: Hammouda, Omar, et al.
Publicado: (2012)

Case Report: Mucopolysaccharidosis Type I Treatment With α-L-Iduronidase Replacement Therapy
por: Li, Ying, et al.
Publicado: (2022)

Biochemical parameters and oxidative stress markers in Tunisian patients with periodontal disease
por: Gharbi, Ahmed, et al.
Publicado: (2019)

Metabolic interactions between hyperhomocysteinemia and endothelin-1 among Tunisian patients with acute coronary diseases
por: Chalghoum, Abdelkader, et al.
Publicado: (2015)

Concomitant Effects of Ramadan Fasting and Time-Of-Day on Apolipoprotein AI, B, Lp-a and Homocysteine Responses during Aerobic Exercise in Tunisian Soccer Players
por: Hammouda, Omar, et al.
Publicado: (2013)

Relationship between the A(8002)G intronic polymorphism of pre-pro-endothelin-1 gene and the endothelin-1 concentration among Tunisian coronary patients
por: Chalghoum, Abdelkader, et al.
Publicado: (2015)

A rare late progression form of Sly syndrome mucopolysaccharidosis
por: Guffon, Nathalie, et al.
Publicado: (2019)

Three novel α-L-iduronidase mutations in 10 unrelated Chinese mucopolysaccharidosis type I families
por: Sun, Luning, et al.
Publicado: (2011)

Identification of mutations that causes glucose-6-phosphate transporter defect in tunisian patients with glycogenosis type 1b
por: Chkioua, Latifa, et al.
Publicado: (2023)

Relationship of activin A levels with clinical presentation, extent, and severity of coronary artery disease
por: Bouzidi, Nadia, et al.
Publicado: (2017)

Enzyme replacement with transferrin receptor-targeted α-L-iduronidase rescues brain pathology in mucopolysaccharidosis I mice
por: Kida, Sachiho, et al.
Publicado: (2023)

Genotypic and bioinformatic evaluation of the alpha-l-iduronidase gene and protein in patients with mucopolysaccharidosis type I from Colombia, Ecuador and Peru
por: Pineda, Tatiana, et al.
Publicado: (2014)

A novel p.E276K IDUA mutation decreasing α-L-iduronidase activity causes mucopolysaccharidosis type I
por: Prommajan, Korrakot, et al.
Publicado: (2011)

Mesenchymal Stem Cells Do Not Prevent Antibody Responses against Human α-L-Iduronidase when Used to Treat Mucopolysaccharidosis Type I
por: Martin, Priscila Keiko Matsumoto, et al.
Publicado: (2014)

Report of 5 novel mutations of the α-L-iduronidase gene and comparison of Korean mutations in relation with those of Japan or China in patients with mucopolysaccharidosis I
por: Kwak, Min Jung, et al.
Publicado: (2016)

Alpha‐L‐iduronidase deficiency: A novel mutation resulting in severe early presentation of Mucopolysaccharidosis type I and literature review of the molecular basis
por: Al Zaabi, Nuha Nasser, et al.
Publicado: (2022)

Fulminant Neonatal Liver Failure in MPV 17-Related Mitochondrial DNA Depletion Syndrome
por: Abduljalil, Razan, et al.
Publicado: (2023)

Comment on “report of 5 novel mutations of the α-L-iduronidase gene and comparison of Korean mutations in relation with those of Japan or China in patients with mucopolysaccharidosis I”
por: Poletto, Edina, et al.
Publicado: (2018)

Particularité de la cystinose infantile chez l'enfant tunisien
por: Jellouli, Manel, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_tag7kumthfcj7thlbq6mh6dupk